MOTT DAVID M Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
30
Insider Buys Sum
$318.14M
Insider Sells Quantity
3
Insider Sells Sum
$138.46M

Insider Activity of MOTT DAVID M

According to the SEC Form 4 filings, MOTT DAVID M, being in a position of

  1. director at Ardelyx, Inc.,
    оver the last 12 months, has bought 333333 shares for $1.95M, and sold 0 shares,
    over all time since 2015-06-05, has bought 9661591 share for $78.39M, and sold 0 shares.

Biography of MOTT DAVID M

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $1,946,3311100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-02-20PurchaseArdelyx, Inc.
ARDX
director
333,333
0.1398%
$5.84$1.95M-6.81%
2025-06-16PurchaseArdelyx, Inc.
ARDX
director
200,000
0.0829%
$3.63$725,880+61.48%
2025-06-09PurchaseArdelyx, Inc.
ARDX
director
200,000
0.082%
$3.69$737,260+57.18%
2025-05-15PurchaseArdelyx, Inc.
ARDX
director
100,000
0.0407%
$3.29$329,120+72.49%
2025-05-02PurchaseArdelyx, Inc.
ARDX
director
381,377
0.1636%
$4.22$1.61M+40.07%
2025-02-24PurchaseArdelyx, Inc.
ARDX
director
77,729
0.0322%
$5.00$388,738+4.68%
2025-01-21PurchaseArdelyx, Inc.
ARDX
director
199,000
0.0854%
$4.99$992,672+8.35%
2024-12-19PurchaseArdelyx, Inc.
ARDX
director
213,300
0.0889%
$4.67$996,580+10.87%
2024-11-13PurchaseArdelyx, Inc.
ARDX
director
215,868
0.0924%
$4.62$996,598+14%
2022-11-17PurchaseArdelyx, Inc.
ARDX
director
567,000
0.3666%
$1.76$1M+111.63%
2021-09-23SaleNovavax, Inc.
NVAX
director
24,961
0.0328%
$252.90$6.31M-71.35%
2020-12-10PurchaseArdelyx, Inc.
ARDX
director
170,000
0.1864%
$5.89$1M+14.19%
2020-06-25PurchaseArdelyx, Inc.
ARDX
director
68,373
0.0772%
$6.96$476,040-4.05%
2020-06-24PurchaseArdelyx, Inc.
ARDX
director
72,598
0.0821%
$6.75$489,862-1.19%
2020-06-22PurchaseArdelyx, Inc.
ARDX
director
4,673
0.005%
$6.75$31,525-6.74%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
900,000
2.6907%
$7.50$6.75M+5.09%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
5M
34.6117%
$10.00$50M-42.9%
2017-11-27SaleAppian Corporation
APPN
10 percent owner
1.14M
2.1156%
$19.49$22.2M+42.78%
2017-11-20SaleAppian Corporation
APPN
10 percent owner
5.64M
11.2735%
$19.49$109.94M+53.66%
2017-10-10PurchaseRhythm Pharmaceuticals, Inc.
RYTM
10 percent owner
550,000
1.3734%
$17.00$9.35M+9.57%
Total: 24
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.